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SCHOOL OF PHARMACY 
OFFICE OF THE DEAN 
University, MS 38677 
Phone: (662) 915-7265 Fax: (662) 915-5704 
 
TO:  All School of Pharmacy Personnel 
 
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs 
 
DATE:  September 5, 2007 
 
SUBJECT: Research News (#3) 
 
 
The following GRANTS/CONTRACTS have recently been awarded: 
1. Dr. Mitchell Avery (P.I. – Medicinal Chemistry). Development and Testing of New Antimalarial Drugs 
(Year 4) (Centers for Disease Control and Prevention), $3,000,000, August 1, 2007-July 31, 2008. 
2. Dr. Joseph Byrd (P.I. – Pharmacy Practice). University of Mississippi Medical Center/University of 
Mississippi School of Pharmacy/Department of Pharmacy Practice – Contract for Residency Training 
Program Support (2007) (University of Mississippi Medical Center), $25,000, July 1, 2007-June 30, 2008. 
3. Dr. Joseph Byrd (P.I. – Pharmacy Practice). University of Mississippi School of Pharmacy/Department of 
Pharmacy Practice/University of Mississippi Medical Center Department of Medicine/Division of Infectious 
Diseases Agreement (2007-2008) (University of Mississippi Medical Center), $13,945, July 1, 2007-June 30, 
2008. 
4. Dr. Joseph Byrd (P.I. – Pharmacy Practice). Delta Diabetes Project (2006-2010) (University of Mississippi 
Medical Center), $38,973, August 1, 2007-July 31, 2010. 
5. Dr. Joseph Byrd (P.I. – Pharmacy Practice). University of Mississippi School of Pharmacy and Baptist 
Memorial Hospital – North Mississippi Agreement (FY 2008) (Baptist Memorial Hospital – North 
Mississippi), $56,250, August 9, 2007-August 8, 2008. 
6. Dr. Joseph Byrd (P.I. – Pharmacy Practice). University of Mississippi School of Pharmacy/Department of 
Pharmacy Practice/University of Mississippi Medical Center Department of Pediatrics Agreement (2007-
2008) (University of Mississippi Medical Center), $23,575, July 1, 2007-June 30, 2008. 
7. Dr. Alice Clark (P.I. – NCNPR/ORSP) and Dr. Ameeta Agarwal (P.I. – NCNPR). New Drugs for 
Opportunistic Infections (Year 18) (National Institute of Allergy and Infectious Diseases) $303,465, July 1, 
2007-June 30, 2008. 
8. Dr. Asok Dasmahapatra (P.I. – NCNPR) and Dr. Kristine Willett (Co-P.I. – Environmental Toxicology 
Research Program/Pharmacology). Ethanol Action in Japanese Medaka: Alteration in Specific Gene 
Methylation (National Institutes of Health – National Institute on Alcohol Abuse and Alcoholism), $69,974, 
July 15, 2007-June 30, 2008.  
9. Dr. Deborah Gochfeld (P.I. – NCNPR). Collaborative Research: Aplysina Red Band Syndrome: 
Investigating the Etiology, Pathogenesis, and Ecology of an Emerging Marine Disease (National Science 




10. Dr. Mark Hamann (P.I. – Pharmacognosy), Dr. Larry Walker (Co-P.I. – NCNPR) and Dr. Mitchell Avery 
(Co-P.I. – Medicinal Chemistry), Anti-AIDS Agents from Marine Organisms (FY 2007-08) (National 
Institute of Allergy and Infectious Diseases) $336,448, June 1, 2007-May 31, 2008. 
11. Dr. Muhammad Ilias (P.I. – NCNPR), Dr. Babu Tekwani (Co-P.I. – NCNPR), and Dr. Ikhlas Khan (Co-
P.I. – NCNPR). Standardization of Banisteriopsis caapi for Chemical and Biological Markers (National 
Institutes of Health), $180,000, August 1, 2007-April 30, 2008. 
12. Dr. Melissa Jacob (P.I. – NCNPR). Anti-Fungal Testing of New Drugs (Florida A&M University/National 
Institutes of Health), $20,473, June 1, 2007-May 31, 2008. 
13. Dr. Soumyajit Majumdar (P.I. – Pharmaceutics). Localized Modulation of RPE P-gp/MRP Activity for 
Back-of-the-Eye Drug Delivery (National Institutes of Health/National Eye Institute), $105,974, September 1, 
2007-August 31, 2008. 
14. Dr. Rae Matsumoto (P.I. – Pharmacology). Center for Research Excellence in Natural Products 
Neuroscience (Year 2) (National Center for Research Resources), $2,008,518, July 1, 2007-June 30, 2008. 
15. Dr. S. Narasimha Murthy (P.I. – Pharmaceutics). Electrically Mediated Trans-Nail Delivery of Drugs 
(Transport Pharmaceuticals, Inc.), $128,187.60, September 1, 2007-August 31, 2008. 
16. Dr. Dale Nagle (P.I. – Pharmacognosy), and Dr. Yu-Dong Zhou (P.I. – Pharmacognosy). Neosergiolide – 
The First Potent Bi-Functional Natural Product that Simultaneously Targets STAT3-Dependent Breast 
Tumors and Tumor Hypoxia (U.S. Army Medical Research and Material Command), $108,000, September 
15, 2007-October 14, 2008. 
17. Dr. Zia Shariat-Madar (P.I. – Pharmacology). Summer Research Opportunities for Undergraduates (Brian 
LeBaron) (University of Southern Mississippi/Mississippi Functional Genomics Network/National Institutes 
of Health), $1,000, June 1, 2007-August 25, 2007. 
18. Dr. Marc Slattery (P.I. – Pharmacognosy), and Dr. Deborah Gochfeld (Co-P.I. – NCNPR). New Ocean 
Resources: Exploration and Drug Discovery in the “Twilight Zone” (Year 2) (U.S. Department of 
Commerce/National Oceanic and Atmospheric Administration), $156,000, May 1, 2007-April 30, 2008. 
19. Dr. Larry Walker (P.I. – NCNPR). Development of Natural Products from Plants and Microbes for 
Replacement of Synthetic Pesticides (Year 2) (U.S. Department of Agriculture/Agricultural Research 
Service), $2,411,643, September 6, 2006-July 31, 2011. 
20. Dr. Larry Walker (P.I. – NCNPR), Dr. Ikhlas Khan (Co-P.I. – NCNPR), Dr. Babu Tekwani (Co-P.I. – 
NCNPR), Dr. Dhammika Nanayakkara (Co-P.I. – NCNPR), and Dr. Muhammad Ilias (P.I. – NCNPR). A 
Longer View of the Antimalarial Drug Pipeline: Natural Products as New Prototypes (Medicines for Malaria 
Venture), $180,579.19, July 1, 2007-December 31, 2007. 
21. Dr. Barbara Wells (P.I. – Dean’s Office), and Dr. Charles Hufford (Co-P.I. – Dean’s Office). Health Care 
Facilities and Other Construction: Equipment for Phase II – NCNPR Program (Health Resources and Services 
Administration), $639,917, August 1, 2007-September 30, 2007. 
22. Dr. Noel Wilkin (P.I. – Pharmacy Administration). 8th Statement of Work 1d3 Quality Improvement 
Organization Intervention and Support Using Integrated Data (Information and Quality Healthcare/Centers for 
Medicare and Medicaid Services), $1,500,000, January 1, 2007-July 31, 2008. 
23. Dr. John Williamson (P.I. – Medicinal Chemistry). Mississippi Functional Genomics Network (University 
of Southern Mississippi/National Institutes of Health), $98,431, May 1, 2007-April 30, 2008. 
 
The following PUBLICATIONS have appeared: 
1. J.D. Bauer, J.A. Sunman, M.S. Foster, J.R. Thompson, A.A. Ogonowski, Stephen Cutler, S.W. May and 
S.H. Pollock, “The Anti-inflammatory Effects and Mechanisms of 4-Phenyl-3-butenoic Acid and 5-
(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide 
Bioactivation”, Journal of Experimental and Pharmacological Therapeutics, 320, 1171-1177 (2007). 
2. Charles Cantrell, D.D. Cook, Franck Dayan and Daneel Ferreira, “Phytochemical Society of North 
America 2006 Annual Meeting Scientific Highlights”, Phytochemistry, 68, 1826-829 (2007). 
3. K.M. Dale, C.M. White, Nickole Henyan, J. Kluger and C.I. Coleman, “Impact of Statin Dosing Intensity on 
Transaminase and Creatine Kinase”, The American Journal of Medicine, 120, 706-712 (2007). 
4. D. Grigore, N.B. Ojeda, E.B. Robertson, A.S. Dawson, C.A. Huffman, Erick Bourassa, Robert Speth, K.B. 
Brosnihan and B.T. Alexander, “Placental Insufficiency Results in Temporal Alterations in the Renin 
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Angiotensin System in Male Hypertensive Growth Restricted Offspring”, The American Journal of 
Physiology – Regulatory, Integrative and Comparative Physiology, 293, 804-811 (2007). 
5. J.L. Grobe, A.P. Mecca, M. Lingis, V. Shenoy, T.A. Bolton, J.M. Machado, Robert Speth, M.K. Raizada and 
M.J. Katovich, “Prevention of Angiotensin II-induced Cardiac Remodeling by Angiotensin-(1–7), American 
Journal of Physiology – Heart and Circulatory Physiology, 292, 736-742 (2007). 
6. S.P. Haris, Y. Zhang, B. Le Bourdonnec, Christopher McCurdy and P.S. Portoghese, “ο-
Napththalenedicarboxaldehyde Derivative of 7’-Aminonaltrindole as a Selective δ-Opioid Receptor Affinity 
Label”, Journal of Medicinal Chemistry, 50, 3392-3396 (2007).  
7. Wimal Herath, Daneel Ferreira and Ikhlas Khan, “Microbial Metabolism. Part 7: Curcumin”, Natural 
Product Research, 21, 444-450 (2007). 
8. Vardan Karamyan and Robert Speth, “Enzymatic Pathways of the Brain Renin-Angiotensin System: 
Unsolved Problems and Continuing Challenges”, Regulatory Peptides, 143, 15-27 (2007). 
9. Vardan Karamyan and Robert Speth, “Identification of a Novel non-AT1, non-AT2 Angiotensin Binding 
Site in the Rat Brain”, Brain Research, 1143, 83-91 (2007). 
10. R.J. Kokje, W.L. Wilson, T.E. Brown, Vardan Karamyan, J.W. Wright and Robert Speth, “Central Pressor 
Actions of Aminopeptidase-Resistant Angiotensin II Analogs”, Hypertension (Journal of the American Heart 
Association), 49, 1328-1335 (2007). 
11. Guoyi Ma, S.A. Bavadekar, Y.M. Davis, S.G. Lalchandani, R. Nagmani, B.T. Schaneberg, Ikhlas Khan and 
D.R. Feller, “Pharmacological Effects of Ephedrine Alkaloids on Human α1- and α2-Adrenergic Receptor 
Subtypes”, The Journal of Pharmacology and Experimental Therapeutics, 322, 214-221 (2007). 
12. D.F. Matesic, K.N. Villio, S.L. Folse, E.L. Garcia, Stephen Cutler and H.G. Cutler, “Inhibition of 
Cytokinesis and Akt Phosphorylation by Chaetoglobosin K in ras-transformed Epithelial Cells”, Cancer 
Chemotherapy and Pharmacology, 57, 709-718 (2006).  
13. P.K. Mididoddi and Michael Repka, “Characterization of Hot-Melt Extruded Drug Delivery Systems for 
Onychomycosis”, European Journal of Pharmaceutics and Biopharmaceutics, 66, 95-105 (2007). 
14. Q.C. Moore III, L. Johnson, Michael Repka and L.S. McDaniel, “Immunization with PspA Incorporated into 
a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae∇”,  Clinical 
and Vaccine Immunology, 789-791 (2007). 
15. Ilias Muhammad and Volodymyr Samoylenko, “Antimalarial Quassinoids: Past, Present and Future”, 
Expert Opinion on Drug Discovery, 2, 1065-1084 (2007). 
16. J. Mustafa, Shabana Khan, Daneel Ferreira and Ikhlas Khan, “Synthesis, Spectroscopic and Anti-tumor 
Studies of Polyphenol-linoleates Derived from Natural Polyphenols”, European Journal of Lipid Science and 
Technology, 109, 552-559 (2007). 
17. A.E. Philip, J.H. Poupaert, G. Cheve, G. Muccioli, D. Lambert and Christopher McCurdy, “Structure-
Activity Relationships of Phenytoinergic Antiepileptic Drugs Related to Ameltolide”, Medicinal Chemistry 
Research (2007).  
18. S. Prodduturi, K.L. Urman, J.U. Otaigbe and Michael Repka, “Stabilization of Hot-Melt Extrusion 
Formulations Containing Solid Solutions Using Polymer Blends”, AAPS PharmSciTech, 8 (2007). 
19. Mohamed Radwan, Susan Manly and Samir Ross, “Two New Sulfated Sterols from the Marine Sponge 
Lendenfeldia dendyi”, Natural Product Communications, 2, 901-904 (2007). 
20. Muntha Reddy, Sashi Gupta, Melissa Jacob, Shabana Khan and Daneel Ferreira, “Antioxidant, 
Antimalarial and Antimicrobial Activities of Tannin-Rich Fractions, Ellagitannins and Phenolic Acids from 
Punica granatum L.”, Planta Medica, 73, 461-467 (2007). 
21. Daniel Riche, “Alternative Viewpoints – Impracticality of Cinnamon Supplements in Diabetes”, 
Pharmacotherapy, 27, 48-50 (2007). 
22. Daniel Riche and Katie McClendon, “Role of Statins for the Primary Prevention of Cardiovascular Disease 
in Patients with Type 2 Diabetes Mellitus”, American Journal of Health-System Pharmacists, 64, 1603-1610 
(2007). 
23. D.E. Stec, C. Bishop, John Rimoldi, S.R. Poreddy, T. Vera and A.K. Salahudeen, “Carbon Monoxide (CO) 




24. S.M. Trey, D.A. Wicks, P.K. Mididoddi and Michael Repka, “Delivery of Itraconazole from Extruded HPC 
Films”, Drug Development and Industrial Pharmacy, 33, 727-735 (2007). 
25. C.B. Willmore-Fordham, D.M. Krall, Christopher McCurdy and D.H. Kinder, “The Hallucinogen Derived 
from Salvia divinorum, Salvinorin A, Has -κ-opioid Agonist Discriminative Stimulus Effects in Rats”, 
Neuropharmacology  (2007). 
26. DA Wright, R Dawson, Stephen Cutler, HG Cutler, CE Orano-Dawson, “Screening of Natural Product 
Biocides for Control of Non-indigenous Species”, Environmental Technology, 28, 309-319 (2007). 
27. D.A. Wright, R. Dawson, Stephen Cutler, H.G. Cutler, C. Orano-Dawson and E. Graneli, “Naphthoquinones 
as Broad Spectrum Biocides for Treatment of Ship’s Ballast Water: Toxicity to Phytoplankton and Bacteria”, 
Water Research, 41, 1294-1302 (2007). 
 
TECHNOLOGY TRANSFER transactions:  
(In the interest of protecting confidential information, the names and titles associated with School of Pharmacy 
invention disclosures and patent applications will no longer be published until after a patent has issued.) 
Research Disclosures Filed in FY2007-2008: 3 
U. S. Patent Applications Pending:  29 
Recent U. S. Patents Granted:    Enzymatic method to produce 7-dehydropregnenolone, vitamin 
D like compounds and derivatives thereof. Slominski, Andrzej; Tuckey, Robert; Zjawiony, Jordan; Stewart, 
D. Jeremy; Wortsman, Jacobo. US Patent #7,253,393. 
 
The following SPECIAL ANNOUNCEMENTS are also listed: 
• Mr. Sanju Narayanan (Medicinal Chemistry Graduate Student) has been selected to participate in the 
2007 American Association of Pharmaceutical Scientists Graduate Student Symposium in Drug Design 
and Discovery, sponsored by Bristol-Myers Squibb, to be held in November in San Diego, California.  
This is the second year in a row that a graduate student from the University of Mississippi has been 
selected for this prestigious recognition. 
• Mr. Srinivasa Murthy Sammeta (Pharmaceutics Graduate Student) received a Graduate Student 
Council Research Grant for 2007-08 funded by the Graduate Student Council of the University of 
Mississippi for his project entitled, “Needle Free Method of Measuring Blood Glucose”. 
• Mr. Sridhar Thumma (Pharmaceutics Graduate Student) was presented with an outstanding podium 
presentation award for his podium entitled, “Transmucosal Delivery of a Pro-drug ∇9-
Tetrahydrocannabinol” at the Pharmforum 2007 conference, hosted by the University of Tennessee 
Student Chapter of the American Association of Pharmaceutical Scientists (AAPS) in May 2007.  Mr. 
Thumma also received the Natural Products Neuroscience (CORE-NPN) Fellowship funded by the 
National Institutes of Health for 2006-07. 
• Ms. Sanpada Upadhye (Pharmaceutics Graduate Student) was presented with the Best Poster Award in 
Health Sciences II category for her poster entitled, “Wound Healing Potential of Chlorophyllin Gel” at the 
University of Mississippi Sigma Xi Poster Symposium in March 2007.  Ms. Upadhye also won the 
outstanding poster award during the AAPS Pharmforum 2007 conference. 
• Mr. Siva Ram Kiran Vaka (Pharmaceutics Graduate Student) also received a UM Graduate Student 
Council Research Grant for 2007-08 for his project entitled, “Enhancement of Brain Uptake of 
Intranasally Administered Macromolecular Therapeutics”. 
• Ms. Jiajia Wang (Pharmacology Graduate Student) and Ms. Lu Wang (Pharmacology Graduate 
Student) became the inaugural recipients of the Marvin Davis Award for the best pre-candidacy graduate 
student in the Department of Pharmacology Awards ceremony on August 24, 2007.  The award is named 
in honor of Dr. Marvin Davis, who was the founding Chair of the Department, and is awarded for 
“outstanding performance as a graduate student in research, scholarship and service to the Department”.  
Jiajia Wang is a graduate student in the laboratory of Dr. Rae Matsumoto and Lu Wang is a graduate 
student in the laboratory of Dr. Kristine Willett. 
 
Please continue to send me important research and graduate information so that I might share it with your faculty 
colleagues.  This information is now being posted on the School of Pharmacy web page 




cc: Dean Barbara G. Wells 
 Ms. Dabney Weems  
 Ms. Julie Edgington, Office of Research 
